2024 HCPCS Code J0576
Injection, buprenorphine extended-release (brixadi), 1 mg
TAGS: buprenorphine
| Notice | HCPCS J0576 terminated on March 31, 2024. |
| Short Description | Inj buprenorph (brixadi) 1mg |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | April 01, 2024 |
| HCPCS Code Added Date | January 01, 2024 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J2260 - Inj milrinone lactate / 5 mg
- J2265 - Minocycline hydrochloride
- J2267 - Inj, mirikizumab-mrkz, 1 mg
- J2270 - Morphine sulfate injection
- J2271 - Morphine so4 injection 100mg
- J2272 - Inj, morphine (fresenius)
- J2274 - Inj morphine pf epid ithc
- J2275 - Morphine sulfate injection
- J2277 - Inj, motixafortide, 0.25 mg
- J2278 - Ziconotide injection
- J2280 - Inj, moxifloxacin 100 mg
- J2281 - Inj moxifloxacin (fres kabi)
- J2300 - Inj nalbuphine hydrochloride
- J2305 - Inj, nitroglycerin, 5 mg
- J2310 - Inj naloxone hydrochloride
- J2311 - Inj, naloxone hcl (zimhi)
- J2315 - Naltrexone, depot form
- J2320 - Nandrolone decanoate 50 mg
- J2323 - Natalizumab injection
- J2325 - Nesiritide injection